CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records
CeriBell, Inc. (CBLL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Canaccord Genuity Maintains Buy on CeriBell, Lowers Price Target to $25
CeriBell, Inc. (CBLL) Q1 2026 Earnings Call Transcript
CeriBell Inc (CBLL) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Market ...
CeriBell Q1 Earnings Call Highlights
CeriBell (CBLL) Q1 2026 Earnings Transcript
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates
Ceribell Inc (NASDAQ:CBLL) Q1 Revenue Beats Estimates, Net Loss Widens, Full-Year Guidance Raised
Ceribell Reports First Quarter 2026 Financial Results
CeriBell Raises FY2026 Sales Guidance from $111.000M-$115.000M to $112.000M-$116.000M vs $113.138M Est
CeriBell Q1 EPS $(0.52) Misses $(0.39) Estimate, Sales $26.494M Beat $26.088M Estimate
Phibro Animal Health (PAHC) Q3 Earnings and Revenues Surpass Estimates
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
Ceribell (CBLL) Rose 91% after Reporting Inline Financial Results
CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium
CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord
CeriBell Inc (CBLL) Q4 2025 Earnings Call Highlights: Revenue Surge and Market Expansion Amid ...
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.